| ImmuneRegen Biosciences, Inc. Patent applications |
| Patent application number | Title | Published |
|---|
| 20100267616 | ACUTE RESPIRATORY SYNDROMES - Substance P or its analogs are useful for treating and protecting against acute respiratory syndromes including ARDS and SARS. The active agents can be administered via inhalation therapy, intravenously, intramuscularly, sublingually, or by other methods. Disease indicia are reduced by substance P treatment. | 10-21-2010 |
| 20100143477 | Methods and Compositions for Stimulating the Proliferation or Differentiation of Stem Cells with Substance Por an Analog Thereof - Compositions and methods are provided for stimulating cell proliferation and differentiation with substance P or a substance P analog. In one embodiment, the methods provide for stimulating or promoting stem cell differentiation by contacting a stem cell with substance P or a substance P analog. In another embodiment, the methods provide for administering to subject an effective amount of substance P or a substance P analog to treat an illness, disease or disorder. | 06-10-2010 |
| 20100062986 | METHOD TO TREAT BLOOD CELL DEPLETION - Neuropeptides are used to treat mammals which have depletion of count of one or more blood cell types. Intramuscular administration or administration via inhalation causes the blood cell count to increase. | 03-11-2010 |
| 20090156504 | METHODS OF TREATING BLOOD CELL DEPLETION - Provided herein are methods and compositions useful for the replenishment of blood cells in a mammal after exposure to therapeutic radiation or drugs. Radiation illness can be reduced in animals by treatment with substance P analogs. In one embodiment, granulocytes can be regenerated after therapeutic radiation by the administration of a substance P analog. In one embodiment, substance P analogs are useful for reducing PARP activity or PARP expression. In one embodiment, substance P analogs are useful for preventing, reducing or ameliorating adverse effects of drugs. In one embodiment, drug induced blood dyscrasias can be ameliorated by the methods and compositions provided herein. | 06-18-2009 |
| 20090137492 | METHOD TO REDUCE THE RISK AND/OR SEVERITY OF ANTHRAX INFECTION - Neuropeptides are used to treat mammals who have been exposed to or who are suspected of having been exposed to spores of | 05-28-2009 |
| 20090099092 | METHODS FOR STIMULATING FIBROBLAST PROLIFERATION USING SUBSTANCE P ANALOGS - Provided herein are methods and compositions for stimulating or promoting fibroblast proliferation. In one embodiment, provided herein are methods and compositions for promoting or enhancing wound healing. | 04-16-2009 |
| 20090075903 | METHOD OF USING SUBSTANCE P ANALOGS FOR TREATMENT AMELIORATION OF MYELODYSPLASTIC SYNDROME - Myelodysplastic syndromes can be treated or ameliorated by the administration of substance P analogs as disclosed herein. | 03-19-2009 |
| 20080318869 | Method to Promote Wound Healing - Wound healing is impaired in irradiated animals. Substance P and its active analogs promote wound healing in irradiated animals. Substance P and its analogs can be used to treat animals irradiated by a nuclear weapon, a nuclear accident, or a therapeutic regimen, for example. Wounds which are susceptible to such treatment include surgical wounds, weapons wounds, disease-caused wounds, bed sores, diabetic ulcers, etc. | 12-25-2008 |
